This table presents recent patent oppositions filed by Regeneron Pharmaceuticals, Inc. against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3819007Dosing Regimen For Anti-Bcma AgentsAMGENAug 2, 2024
EP4058148Dosing Regimen For Anti-Bcma AgentsAMGENAug 2, 2024
EP3631454Treatment Of Lag-3 Positive TumorsBRISTOL-MYERS SQUIBB COMPANYJun 13, 2024
EP3911354Aav-Mediated Gene Therapy Restoring The Otoferlin GeneCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)Apr 16, 2024
EP3666797Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9)AMGENFeb 19, 2024
EP3597216Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses ThereofE. R. SQUIBB & SONS, L.L.C.May 23, 2023
EP3476942Long Germline Dh Genes And Long Hcdr3 AntibodiesTRIANNI, INC.Oct 25, 2022
EP3785536Adam6 Knockin MiceTRIANNI, INC.Oct 25, 2022
EP3241435Animal Models And Therapeutic MoleculesKYMAB LIMITEDFeb 25, 2022
EP3322731Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL-MYERS SQUIBB COMPANYOct 7, 2021

The following table provides an overview of the latest patents of Regeneron Pharmaceuticals, Inc. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3110848Feb 14, 2024Methods For Treating Skin Infection By Administering An Il-4R Antagonist5
EP3515465Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R Inhibitor7
EP3973987Jan 10, 2024Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist6
EP4011915Nov 15, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist6
EP3703818Nov 1, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist7
EP2967015Aug 9, 2023Transgenic Mice Expressing Chimeric Major Histocompatibility Complex (Mhc) Class Ii Molecules1
EP3384049Aug 2, 2023Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-Vegf4
EP2790681Jul 26, 2023Polymer Protein Microparticles1
EP3085780Jun 28, 2023Producing Hybrid Antibodies Containing Human Variable Regions And Rodent Constant Regions1
EP3085779May 31, 2023Method Of Modifying Eukaryotic Cells1